• Home
  • H2 EQUITY PARTNERS (“H2”) IS PLEASED TO ANNOUNCE THAT IT HAS COMPLETED THE SALE OF NRS HEALTHCARE (“NRS”)

H2 EQUITY PARTNERS (“H2”) IS PLEASED TO ANNOUNCE THAT IT HAS COMPLETED THE SALE OF NRS HEALTHCARE (“NRS”)

NRS is the UK’s leading provider of healthcare products and services to support independent living at home. NRS supports local authorities and the NHS through its portfolio of Integrated Community Equipment Services’ contracts, as well as providing clinical services. NRS also has a fast-growing product sales business into the private sector, mainly sold through online channels. Based in Leicestershire, NRS has 1000 FTEs and sales of approximately £200 million.

H2 acquired a majority share of NRS alongside LDC in December 2014. The business grew significantly under H2’s ownership, with a focus on providing a broader range of products and services, as well as a significant investment in new product development, clinical resources and IT capability to support operational delivery and high levels of customer service.

Graphite is a leading UK mid-market private equity firm with strong credentials in the healthcare sector. Graphite will work alongside the existing management team, who remain important shareholders in NRS.

The sale of NRS represents another successful exit from H2 Fund IV, which commenced investing in 2011 and continues to deliver market leading returns.

-->